SCHEMBL4036317

SCHEMBL4036317

Cc1cccnc1C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2ccccc2N1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
EPHX1 P07099 1/20 0.39
C3AR1 Q16581 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4035291 0.84 EGFR (0.42) RAB9ANPC1MEN1KMT2AKDM4E
SCHEMBL4038768 0.83 ALDH1A1 (0.41) RAB9AMEN1KMT2AKDM4EC3AR1
SCHEMBL4040357 0.83 ALDH1A1 (0.41) RAB9AMEN1KMT2AKDM4EC3AR1
SCHEMBL4041338 0.83 SMN1; SMN2 (0.41) HPGDRAB9ANPC1MEN1KMT2A
SCHEMBL4042729 0.82 HPGD (0.44) HPGDRAB9ANPC1MEN1KMT2A
SCHEMBL4041730 0.82 C3AR1 (0.46) HPGDMEN1KMT2AKDM4EC3AR1
SCHEMBL4039913 0.81 TSHR (0.46) HPGDRAB9ANPC1MEN1KMT2A
SCHEMBL4039067 0.80 NPC1 (0.44) HPGDRAB9ANPC1MEN1KMT2A
SCHEMBL4042940 0.79 TSHR (0.45) HPGDRAB9ANPC1MEN1KMT2A
SCHEMBL4034668 0.79 IDO1 (0.43) HPGDRAB9AKMT2AKDM4EEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed